| REVIEW ARTICLE |
|
| Year : 2020 | Volume
: 3
| Issue : 2 | Page : 15-17 |
|
|
Mucormycosis—A potential aftermath post COVID-19: A brief review
Deepti G Jindal1, Varun Jindal2, Akshita S Thakur1
1 Department of Oral Pathology and Microbiology, Bhojia Dental College and Hospital, Bhud, Baddi, District Solan, Himachal Pradesh, India
2 Private practitioner, Panchkula, Haryana, India
Correspondence Address:
Deepti G Jindal
Department of Oral Pathology and Microbiology, Bhojia Dental College and Hospital, Bhud, Baddi, District Solan, Himachal Pradesh
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/JHNP.JHNP_11_21
|
|
|
The Corona virus pandemic and its continued streak along with numerous mutations have put forth a major challenge for the medical fraternity worldwide. Due to new disease entity with high infectivity rate and associated fatality, it is proving to be highly challenging by being associated with certain morbidities induced by novel therapeutic protocols. Some of the COVID-19 treated patients suffer with another fatal infection, mucormycosis, commonly called as black fungus and this has posed yet another challenge in fighting the COVID menace. The paper features mucormycosis as a preexisting entity in medical science along with its current hazardous trend with novel corona virus including its management. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
![[JOURNAL_FULL_NAME]](images/logo.png){kind=logo}
